Published on 22 January 2025
Description:
Avalere Health’s Amar Urhekar on his career path; Insights from ASH 2024; The science behind gene-silencing technology
Categories:
Pharmaceutical Market EuropePreview:
25 articles from this collection:
PME January 2025
COMMUNIQUE 2025
Comment
FlyPharma Amsterdam 2025
Contents
News
Roche and Ascidian agree to $1.8bn neurological disease partnership
News
Researchers identify new major cause of inflammatory bowel disease
Dermatology News
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
DARWIN'S MEDICINE - Promiscuous strategists
The evolutionary lessons for Bayer’s management restructure
MIKE DIXON - Back to work
Collecting the right data in the right way for the right reasons
INNOVATIVE IMPACT BLOG - Shaping the future of pharma with human-centric transformation techniques
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
HEALTHCARE - Celebrating collective achievement – the power of collaboration
AMAR URHEKAR AVALERE HEALTH - The power of purpose
Across almost every sector, brands are multiplying their investment in creativity
BIOTECH SPIN-OUTS - Creating and sustaining university biotech spin-outs
Picking your omnichannel direction requires a disciplined, scientific approach
GENE-SILENCING TECHNOLOGY - The silent treatment – researching gene silencing for Alzheimer’s, Parki
Ethical content sharing and the benefits of the CLA Pharmaceutical Licence
ASH 2024 - Keto, CAR-T and creativity: insights from ASH 2024
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
TL Inizio - Communicating AI in healthcare: a guide for effective strategy
What value does your strategic planning add?
AI AND PHARMA MARKETING - RThe AI tipping point in pharma marketing: balancing technology and trust
GENAI AND HEALTHCARE - GenAI and healthcare – potential that goes beyond established technologies
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
AI AND THE HUMAN VOICE - The need for a human touch in an AI world
Appointments
Appointments
Appointments
HEALTHCARE COMMS
PM Society Awards 2025
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services